These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18314216)

  • 1. Implementing non-invasive markers for liver fibrosis in clinical practice.
    Sebastiani G; Alberti A
    J Hepatol; 2008 May; 48(5):880-1; author reply 881-3. PubMed ID: 18314216
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy.
    Bedossa P
    Liver Int; 2009 Jan; 29 Suppl 1():19-22. PubMed ID: 19207962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines?
    Castera L; Denis J; Babany G; Roudot-Thoraval F
    J Hepatol; 2007 Mar; 46(3):528-9; author reply 529-30. PubMed ID: 17239479
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-invasive biomarkers of liver fibrosis in liver transplant patients with hepatitis C: can we avoid liver biopsies?
    Berenguer M
    Dig Liver Dis; 2009 Mar; 41(3):226-8. PubMed ID: 19138576
    [No Abstract]   [Full Text] [Related]  

  • 5. [Using non-invasive transient elastography for the assessment of hepatic fibrosis].
    Luo JW; Shao JH; Bai J; Cui LG; Wang JR
    Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):395-7. PubMed ID: 16732926
    [No Abstract]   [Full Text] [Related]  

  • 6. [Growth factors in assessing hepatic fibrosis in patients with chronic hepatitis C].
    Ivkova AN; Il'chenko LIu; Kushlinskiĭ NE; Petrenko NV; Storozhakov GI
    Eksp Klin Gastroenterol; 2008; (5):42-6. PubMed ID: 19145916
    [No Abstract]   [Full Text] [Related]  

  • 7. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.
    Castéra L; Le Bail B; Roudot-Thoraval F; Bernard PH; Foucher J; Merrouche W; Couzigou P; de Lédinghen V
    J Hepatol; 2009 Jan; 50(1):59-68. PubMed ID: 19013661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C.
    Boursier J; Bacq Y; Halfon P; Leroy V; de Ledinghen V; de Muret A; Bourlière M; Sturm N; Foucher J; Oberti F; Rousselet MC; Calès P
    Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):28-38. PubMed ID: 19060630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive biomarkers FibroTest-ActiTest for replacing invasive liver biopsy: the need for change and action.
    Munteanu M
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):173-4. PubMed ID: 17592566
    [No Abstract]   [Full Text] [Related]  

  • 10. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
    Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
    Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum fibrosis markers to predict clinical and histological progression in hepatitis C non-responders.
    Malik R; Schuppan D
    Gut; 2010 Oct; 59(10):1312-3. PubMed ID: 20833662
    [No Abstract]   [Full Text] [Related]  

  • 12. External validation of FibroIndex.
    Halfon P; Penaranda G; Renou C; Bourliere M
    Hepatology; 2007 Jul; 46(1):280-1; author reply 281-2. PubMed ID: 17596884
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimized stepwise combination algorithms of non-invasive liver fibrosis scores including Hepascore in hepatitis C virus patients.
    Bourliere M; Penaranda G; Ouzan D; Renou C; Botta-Fridlund D; Tran A; Rosenthal E; Wartelle-Bladou C; Delasalle P; Oules V; Portal I; Castellani P; Lecomte L; Rosenthal-Allieri MA; Halfon P
    Aliment Pharmacol Ther; 2008 Aug; 28(4):458-67. PubMed ID: 18498446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HCV serum proteome: a search for fibrosis protein markers.
    Cheung KJ; Tilleman K; Deforce D; Colle I; Van Vlierberghe H
    J Viral Hepat; 2009 Jun; 16(6):418-29. PubMed ID: 19226329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndecan 1 (CD138) serum levels: a novel biomarker in predicting liver fibrosis stage in patients with hepatitis C.
    Zvibel I; Halfon P; Fishman S; Penaranda G; Leshno M; Or AB; Halpern Z; Oren R
    Liver Int; 2009 Feb; 29(2):208-12. PubMed ID: 18694404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C.
    Morra R; Lebray P; Ingiliz P; Ngo Y; Munteanu M; Ratziu V; Poynard T
    Hepatology; 2008 Jan; 47(1):353-4; author reply 354-6. PubMed ID: 18161711
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
    Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
    J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.
    Castera L
    J Viral Hepat; 2009 May; 16(5):300-14. PubMed ID: 19254351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the effect of splenectomy on hepatic functional reserve and structural damage in patients with chronic hepatitis C virus infection by non-invasive serum markers. A prospective study.
    Elsebae MM; Abu-Zekri NB
    Int J Surg; 2008 Oct; 6(5):362-6. PubMed ID: 18662898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.